Roche
RHHBY
$48.78
Share price
0.93%
Change (1 day)
22.05%
Change (1 year)
Categories
Market capitalization of Roche (RHHBY)
Market cap: $334.23 Billion
As of November 2021 Roche has a market cap of $334.23 Billion. This makes Roche the world's 25th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Roche from 2006 to 2021
| Year | Market cap | Change |
|---|---|---|
| 2021 | $335.79 B | 11.02% |
| 2020 | $302.45 B | 9.48% |
| 2019 | $276.26 B | 31.28% |
| 2018 | $210.43 B | -2.03% |
| 2017 | $214.79 B | 9.78% |
| 2016 | $195.65 B | -17.9% |
| 2015 | $238.31 B | 2.9% |
| 2014 | $231.58 B | -2.73% |
| 2013 | $238.08 B | -24.5% |
| 2012 | $315.35 B | 114.15% |
| 2011 | $147.25 B | 15.58% |
| 2010 | $127.41 B | -14.34% |
| 2009 | $148.74 B | 12.84% |
| 2008 | $131.81 B | -12.81% |
| 2007 | $151.17 B | -2.03% |
| 2006 | $154.31 B |
End of Day market cap according to different sources
On Nov 29th, 2021 the market cap of Roche was reported to be:
$331.14 Billion
$331.14 Billion
$0 Million
$272.08 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap difference | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $410.50 B | 22.82% | 🇺🇸 USA |
 Novartis NVS | $178.29 B | -46.66% | 🇨🇭 Switzerland |
 Pfizer PFE | $301.57 B | -9.77% | 🇺🇸 USA |
 Abbott Laboratories ABT | $222.39 B | -33.46% | 🇺🇸 USA |
 Amgen AMGN | $112.02 B | -66.48% | 🇺🇸 USA |
 Sanofi SNY | $119.42 B | -64.27% | 🇫🇷 France |
 Becton Dickinson BDX | $67.35 B | -79.85% | 🇺🇸 USA |
 Merck MRK | $189.21 B | -43.39% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $103.45 B | -69.05% | 🇬🇧 UK |